Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
310.15
-2.71 (-0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
40
41
Next >
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
January 09, 2022
The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement
January 06, 2022
From
Generate Biomedicines
Via
Business Wire
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Expert Ratings For Amgen
January 05, 2022
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the l...
Via
Benzinga
Expert Ratings For Amgen
December 21, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Upgrades According to TD Securities, the prior rating for Canada Goose Holdings Inc (NYSE:
Via
Benzinga
Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season
January 04, 2022
The U.S. dollar was rising against the Japanese yen Tuesday morning as foreign investors take notice of the jump in United States Treasury yields. The Japanese yen is now trading...
Via
Benzinga
Dogs Of The Dow Performance Does Not Keep Pace In 2021
January 01, 2022
In this past year, the 'Dogs of the Dow' strategy did not keep pace with either the Dow Jones Index or the S&P 500 Index. The Dow Dogs generated a total return of 16.3% versus 20.8% for the DJIA and...
Via
Talk Markets
Dogs of Major Indices
December 30, 2021
As we approach the end of 2021, we take a look at the ten Dow stocks that would currently make up the Dogs of the Dow for 2022.
Via
Talk Markets
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
The Dow Jones Industrial Average is a price-weighted index consisting of 30 stocks. It's one of the oldest and best-known measures of stock market performance. The blue-...
Via
Benzinga
Best Stocks For Wheel Strategy Trades: Use These In 2022
December 26, 2021
Blue chips companies, high dividend stocks, REITs, and low beta ETFs work well when employing the wheel strategy.
Via
Talk Markets
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
December 22, 2021
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
Via
InvestorPlace
Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level
December 21, 2021
The FDA has approved Amgen Inc's (NASDAQ: AMGN) Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or...
Via
Benzinga
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
December 20, 2021
Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a ...
Via
Benzinga
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
December 21, 2021
Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...
Via
FinancialNewsMedia
Exposures
Product Safety
AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
December 20, 2021
The FDA has approved AstraZeneca plc (NASDAQ: AZN) / Amgen Inc's (NASDAQ: AMGN) Tezspire (tezepelumab-ekko) as add-on maintenance treatment of adult...
Via
Benzinga
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...
Via
Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...
Via
Benzinga
Up More Than 750%, This Stock Just Increased Its Dividend Again
December 17, 2021
Dividend growth investing is like the gift that keeps on giving. Except it's better than that. It's the gift that keeps giving more... and more... and more.
Via
Talk Markets
Check Out What Whales Are Doing With AMGN
December 16, 2021
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
2 Top Dividend Stocks That Just Hiked Their Payouts by 10% or More
December 13, 2021
And there could be even more increases in the future.
Via
The Motley Fool
5 Dividend Growth Stocks Getting Crushed… Time To Buy?
December 11, 2021
We have a disconnect between business performance and stock performance. And we have a disconnect between individual stocks and the stock market. These disconnects could lead us to fantastic long-term...
Via
Talk Markets
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
December 10, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 10, 2021 – USA News Group – Researchers led by a scholar from City University of Hong Kong (CityU) have developed a novel...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
Can-Fite BioPharma Ltd (NYSE: CANF) announced that the last of approximately 400 psoriasis patients enrolled in its Phase 3 Comfort study is scheduled to complete a 16-week...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
What 8 Analyst Ratings Have To Say About Amgen
December 06, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027
December 08, 2021
Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...
Via
FinancialNewsMedia
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.